
- 积分
- 0
- 威望
- 0
- 包包
- 23
|
本帖最后由 细胞海洋 于 2011-10-20 13:25 编辑
" z9 T7 Y5 ?+ \4 \0 C N0 Y* Y# F6 W' F, [& w o4 {% I7 H
Zhiqiang An, "Therapeutic Monoclonal Antibodies: From Bench to Clinic" $ T+ @3 |0 { I% g, k, v5 M; r
Wiley | 2009 | ISBN: 0470117915 | 905 pages | PDF | 11,4 MB
8 @5 A: R; x. B# P+ z
0 _# C0 o* P9 T9 U8 Y70-chapter authoritative reference that covers therapeutic monoclonal antibody discovery, development, and clinical applications while incorporating principles, experimental data, and methodologies.
' ?% C3 D- ?4 ?0 v2 w' ^2 ~2 n4 a. qFirst book to address the discovery and development of antibody therapeutics in their entirety.8 {* E8 W4 n5 i+ b8 K& z" L
Most chapters contain experimental data to illustrate the principles described in them.8 s: j; j. y( N, O) x2 \
Authors provide detailed methodologies that readers can take away with them and use in their own laboratories" D0 ^1 m m: x/ j" j' J
2010-7-12 18:23:52 上传下载附件 (32.22 KB)
# Q' p2 o# Z# v6 `# x% y
/ D4 e) h: r: l6 P( D4 [. BTHERAPEUTIC MONOCLONAL ANTIBODIES -141 b7 m* e" b6 N7 V
CONTENTS -12
* Z j( e* n' P) R7 r4 s' R( N1 y FOREWORD -86 }% m! w( | g( i0 e( Y
PREFACE -6- P: W6 n( c& ?( B+ l
CONTRIBUTORS -4
- ~# @$ Q8 A+ T% }4 h: W7 \( F PART I ANTIBODY BASICS 1" r/ t1 J5 S: c" |1 Y. O: J2 M
1. Therapeutic Monoclonal Antibodies: Past, Present, and Future 3
# H6 D' C: J8 {6 l6 x 2. Antibody Molecular Structure 51
7 a6 g+ s# {" D7 |. L 3. Glycosylation of Therapeutic IgGs 67
5 R* X1 }, _& m- q) g9 x7 \+ n7 S 4. Antibody Databases and Tools: The IMGT(? Experience 91( G& `& Y: e) o$ e, K8 g
PART II ANTIBODY SOURCES 115
" w3 Y3 U7 u3 d* {% v! X 5. Human Antibodies from Transgenic Mice 117, ]* c# y1 K5 Q7 K7 N
6. Rabbit Hybridoma 1519 x* b4 L5 P9 f
7. Human Antibody Repertoire Libraries 169
- k& ~: m$ x3 C4 o PART III IN VITRO DISPLAY TECHNOLOGY 189$ Z% D& l/ j/ {0 @' u \
8. Antibody Phage Display 191$ O8 ~0 G3 g* ]
9. Yeast Surface Display 213% g. J4 D% t; e
10. Ribosomal Display 2391 {4 R, I2 R+ k8 h3 \+ }# t
11. Bacterial Display of Antibodies 255
. p J6 r& o8 p: Y9 S% y; ~ v 12. Antibody Selection from Immunoglobulin Libraries Expressed in Mammalian Cells 283
4 F$ g- Y: O* P7 g. z# i PART IV ANTIBODY ENGINEERING 309. Q0 s6 O8 v7 y5 _" X8 T; I
13. Antibody Engineering: Humanization, Affinity Maturation, and Selection Techniques 311
& P/ Y: ]6 K' q, ~" [3 b 14. Modulation of Serum Protein Homeostasis and Transcytosis by the Neonatal Fc Receptor 3359 W4 F7 C/ i& v. m3 A. [ l" t% n* W
15. Engineering the Antibody Fc Region for Optimal Effector Function 3496 [7 F; T, \! z& m3 H# q0 ^
PART V PHYSIOLOGY AND IN VIVO BIOLOGY 371
! u2 ?1 K6 F; w' V" P; t- B& v6 n 16. Antibody-Complement Interaction 373- Y/ l3 T+ M" n
17. Bacteria Immunoglobulin-Binding Proteins: Biology and Practical Applications 385
( E& s9 C: k8 |5 A4 o 18. Immunogenicity Screening Using in Silico Methods: Correlation between T-Cell Epitope Content and Clinical Immunogenicity of Monoclonal Antibodies 417
" i# U( ]6 P2 F& G 19. Monoclonal Antibody Pharmacokinetics and Pharmacodynamics 4391 u: M7 S, ?: B. x' ^
20. Biodistribution and Imaging 461
7 A+ N: H6 Z( {4 [4 D" _ 21. Antibodies and the Blood-Brain Barrier 483. Q/ R8 o- p4 _+ n
PART VI ANTIBODY CHARACTERIZATION 503
2 `7 G- @: Z* e- D 22. Determination of Equilibrium Dissociation Constants 505
& E$ P( }3 n+ `( Y( T' }% f 23. Molecular and Functional Characterization of Monoclonal Antibodies 525# w- A+ R; S( s/ E/ @$ b8 r
24. Characterization of Heterogeneity in Monoclonal Antibody Products 541$ ~" t: ]: P& f
PART VII ANTIBODY EXPRESSION 555! T u; A/ M! ~$ D( K$ e/ p4 K- p
25. Antibody Expression in Mammalian Cells 557
! e( T" n& l+ }2 C+ Q 26. Production of Antibodies in Pichia pastoris 573/ i7 Y8 a. j! X: i# C$ M ]4 j4 T
27. Production of Antibody Fab' Fragments in E. coli 589/ j9 \6 `# z4 D- V
28. Production of Human Therapeutic Monoclonal Antibodies in Chicken Eggs 623
1 X0 o6 H. p6 S9 v, j% m 29. Production of Antibodies in Plants 651% ~* s+ k; @# S" t
PART VIII THERAPEUTIC ANTIBODIES 673
; [) Y3 u: m, j8 }$ c1 T0 m" P" _ 30. The Formulation and Delivery of Monoclonal Antibodies 6759 z3 l& b: Z' O# ?3 ?
31. Therapeutic Antibodies in Clinical Use and Leading Clinical Candidates 711
; J6 [" W) D* T, D& v4 l8 u 32. Follow-On Protein Products: What, Where, When, How? 763
6 Q4 a: h4 @6 n$ N+ g8 O3 {5 Q6 T 33. Monomeric Fc Fusion Molecules 779. m8 v2 B& l; _: x/ \- X
34. Radioimmunotherapy: Current Status and Future Directions 797
|3 m" ]' E: T" _ 35. Antibody-Drug Conjugate Therapy 821' q4 i* z8 L/ G/ S* F
ABBREVIATIONS 857
2 e8 e1 j. B# Q Y& ^* M9 w7 c INDEX 865
2 k; b8 B% u4 s9 q9 j5 e; v6 H1 S7 F6 m
[hide][/hide] |
附件: 你需要登录才可以下载或查看附件。没有帐号?注册
-
总评分: 包包 + 10
查看全部评分
|